Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 483,610 | 206,395 | 254,312 | 135,376 | 112,572 |
| Marketable Securities | 43,332 | 39,103 | 55,371 | 91,065 | 136,796 |
| Receivables | 103,035 | 78,447 | 84,564 | 88,156 | 81,917 |
| TOTAL | $665,777 | $339,872 | $413,273 | $325,501 | $357,622 |
| Non-Current Assets | |||||
| PPE Net | 367,955 | 363,913 | 361,883 | 357,423 | 347,450 |
| Investments And Advances | 275,887 | 258,073 | 251,256 | 373,621 | 370,053 |
| Other Non-Current Assets | 13,964 | 21,173 | 20,452 | 17,748 | 14,307 |
| TOTAL | $657,806 | $643,159 | $633,591 | $748,792 | $731,810 |
| Total Assets | $1,323,583 | $983,031 | $1,046,864 | $1,074,293 | $1,089,432 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 95,625 | 78,890 | 81,665 | 58,602 | 53,658 |
| TOTAL | $148,271 | $133,235 | $135,868 | $112,252 | $109,056 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 51,640 | 53,425 | 53,326 | 52,852 | 54,723 |
| Other Non-Current Liabilities | 281,462 | 7,405 | 6,806 | 7,180 | 7,350 |
| TOTAL | $689,580 | $421,543 | $432,962 | $443,950 | $452,561 |
| Total Liabilities | $837,851 | $554,778 | $568,830 | $556,202 | $561,617 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,889 | 92,576 | 91,627 | 90,891 | 89,959 |
| Common Shares | 93 | 92 | 91 | 91 | 89 |
| Retained earnings | -1,267,323 | -1,213,880 | -1,151,515 | -1,089,010 | -1,045,563 |
| Other shareholders' equity | -1,862 | -1,731 | -904 | -2,175 | -2,491 |
| TOTAL | $485,732 | $428,253 | $478,034 | $518,091 | $527,815 |
| Total Liabilities And Equity | $1,323,583 | $983,031 | $1,046,864 | $1,074,293 | $1,089,432 |